MKI67 and breast cancer: A recent study showed that high tumor cell proliferation assessed by Ki-67 was associated with increased levels of all tumor-infiltrating lymphocyte subsets, including CD3+ pan T cells in breast cancer [30], which is consistent with the results of the present study.